American Oriental Bioengineering (AOB) Cash Flow Statement

Click line-items for a historical chart and %

Net income	-55.13M
Depreciation and amortization	9.09M
Amortization of deferred issuance cost
Loss on disposal of property, plant and equipment	0
Stock-based consulting expenses	0
(Reversal) /Provision of doubtful accounts and slow moving inventories
Deferred taxes	617.08K
Stock-based compensation expenses	1.19M
Equity in (earnings) /losses from unconsolidated entities	2.98M
(Gain) /loss on changes in ownership of unconsolidated entities
Independent director stock compensation
Accounts and notes receivable
Inventories	-289.28K
Advances to suppliers and prepaid expenses	-187.24K
Other current assets	441.88K
Accounts payable	-3.66M
Other payables and accrued expenses	2.44M
Taxes payable	-494.72K
Other liabilities
Unrecognized tax benefits
Net cash provided by operating activities	-21.93M
Purchases of property, plant and equipment	-15.12M
Purchases of construction in progress
Deposit for long-term assets
Advances to equity investments
Proceeds from disposal of property, plant and equipment	0
Net cash used in investing activities	-10.68M
Proceeds from loans	39.58M
Repayment of loans	-14.9M
Repurchase of common stock	0
Net cash (used in) provided financing activities	27.07M
Effect of exchange rate changes on cash and cash equivalents	1.67M
NET INCREASE IN CASH AND CASH EQUIVALENTS	-3.87M
Cash and cash equivalents, beginning of period	7.1M
CASH AND CASH EQUIVALENTS, END OF PERIOD	3.23M

Entities mentioned with AOB

View All Entities